FDA AND CDC FACT SHEET ON USE OF DIFFERENT FACE COVERINGS AGAINST COVID-19

2024-02-07T16:09:22+00:00April 28th, 2020|Categories: Covid-19, USA|Tags: , , |

The FDA developed a fact sheet in collaboration with the Centers for Disease Control and Prevention (CDC) to help answer questions from the food and agriculture sector about what respirators, disposable face masks, such as surgical or medical masks, or [...]

FDA issued guidances on Remote Digital Pathology and Non-invasive Fetal and Maternal Monitoring devices

2024-02-23T16:59:16+00:00April 27th, 2020|Categories: Compliance, USA|Tags: , , , |

FDA issued guidances to provide a policy to help expand the availability of devices for remote reviewing and reporting of scanned digital images of pathology slides and non-invasive fetal and maternal monitoring devices during COVID-19 pandemic. Enforcement Policy for [...]

IMDRF issues guidances on cybersecurity, personalized devices, conformity assessment bodies and terminologies for categorized Adverse Event Reporting (AER)

2024-02-26T11:42:11+00:00April 24th, 2020|Categories: Compliance, Europe, Innovation, Regulatory, Software, USA|Tags: , , , , |

The International Medical Device Regulators Forum (IMDRF) issued on April 20th four technical documents covering cybersecurity, personalized devices, conformity assessment bodies and terminologies for categorized Adverse Event Reporting (AER). Following, a short overview on the content of the guidelines: [...]

European Commission welcomes the MDR delay adoption by the European Parliament and the Council

2024-02-07T15:52:28+00:00April 24th, 2020|Categories: Covid-19, Europe, MDR, Regulatory|Tags: , , |

Medical devices can be sold for another year under the current regulatory framework based on the EU Medical Device Directive (93/42/EEC). The European Commission welcomes the adoption by the European Parliament and the Council of the proposal to postpone [...]

UK: MHRA pragmatic and flexible approach allows special measures for clinical research under COVID-19

2024-02-29T16:18:52+00:00April 22nd, 2020|Categories: Covid-19, UK|Tags: , , , |

UPDATED ON April 22nd, 2020 In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) issued guidance on the management of clinical trials in response to the COVID-19 pandemic. "The MHRA will be as flexible and pragmatic as [...]

FDA: Update for medical device manufacturers in CARES Act

2024-02-26T10:57:19+00:00April 21st, 2020|Categories: Compliance, Covid-19, Regulatory, USA|Tags: , , |

FDA issued indications for medical device manufacturers within the CARES Act: Coronavirus Aid, Relief, and Economic Security Act. General provisions Medical device manufacturers are now required to report permanent discontinuance or interruption in manufacturing for the following categories of [...]

MDCG: possibility to postpone or undergo remote audit for medical device manufacturers during COVID-19

2024-02-26T16:52:20+00:00April 17th, 2020|Categories: Compliance, Covid-19, Europe, Regulatory|

The European Commission’s Medical Device Coordination Group (MDCG) issued a guidance temporarily allowing postponement or remote audits of medical device manufacturers necessary for the re-certification of CE marking and related requirements. Normally, manufacturers must undergo on-site audits by Notified [...]

FDA announces activities against COVID-19 in a new “At-a-Glance Summary”

2024-02-07T16:10:56+00:00April 17th, 2020|Categories: Clinical Trial, Compliance, Covid-19, Regulatory, USA|Tags: , , |

The FDA has posted a new “At-a-Glance Summary” that captures the agency’s major activities in the fight against COVID-19. The FDA has made a wide range of information regarding their activities available to the public on their COVID19 website. [...]

EU Members States and European Commission introduce mobile apps to gradually loosen confinement

2024-02-02T12:16:25+00:00April 17th, 2020|Categories: Covid-19, Europe|Tags: , , , , |

The EC and the EU Members States issued a toolbox for the use of mobile applications for contact tracing and alerting during the coronavirus pandemic. The toolbox is accompanied by guidance on data protection for such mobile app “Contact [...]

Switzerland: Exception for marketing of medical devices under COVID-19

2024-02-29T14:26:41+00:00April 16th, 2020|Categories: Clinical Trial, Covid-19, Europe, Switzerland|Tags: , , , |

The Swiss Federal Council issues a new regulation allowing marketing of devices that have not undergone a conformity assessment procedure. This will not exempt the manufacturer from proving performance of the device and essential requirement fulfilment.  This exception is [...]

Go to Top